ATE199644T1 - Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe - Google Patents
Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffeInfo
- Publication number
- ATE199644T1 ATE199644T1 AT95942007T AT95942007T ATE199644T1 AT E199644 T1 ATE199644 T1 AT E199644T1 AT 95942007 T AT95942007 T AT 95942007T AT 95942007 T AT95942007 T AT 95942007T AT E199644 T1 ATE199644 T1 AT E199644T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfolipidic
- vaccines
- hydrophobic
- polysaccharide
- adjuvants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9401174A BE1008978A5 (fr) | 1994-12-27 | 1994-12-27 | Adjuvants pour vaccins. |
PCT/BE1995/000119 WO1996020008A1 (fr) | 1994-12-27 | 1995-12-21 | Adjuvants pour vaccins |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE199644T1 true ATE199644T1 (de) | 2001-03-15 |
Family
ID=3888560
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95942007T ATE199644T1 (de) | 1994-12-27 | 1995-12-21 | Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe |
AT95942008T ATE248863T1 (de) | 1994-12-27 | 1995-12-21 | Cyclodextrinderivate und verfahren zu deren herstellung |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95942008T ATE248863T1 (de) | 1994-12-27 | 1995-12-21 | Cyclodextrinderivate und verfahren zu deren herstellung |
Country Status (17)
Country | Link |
---|---|
US (2) | US6165995A (de) |
EP (2) | EP0814836B1 (de) |
JP (2) | JP3927235B2 (de) |
CN (2) | CN1132630C (de) |
AT (2) | ATE199644T1 (de) |
AU (2) | AU709104B2 (de) |
BE (1) | BE1008978A5 (de) |
BR (2) | BR9510223A (de) |
CA (2) | CA2208790C (de) |
DE (2) | DE69520376T2 (de) |
DK (2) | DK0814836T3 (de) |
ES (2) | ES2204969T3 (de) |
GR (1) | GR3035941T3 (de) |
MX (1) | MX9704822A (de) |
PT (2) | PT814836E (de) |
SI (1) | SI0800539T1 (de) |
WO (2) | WO1996020008A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1008978A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
US5916883A (en) | 1996-11-01 | 1999-06-29 | Poly-Med, Inc. | Acylated cyclodextrin derivatives |
ES2500490T3 (es) * | 1997-08-29 | 2014-09-30 | Antigenics Inc. | Composiciones que comprenden el adyuvante QS-21 y polisorbato o ciclodextrina como excipiente |
EP1104767A1 (de) * | 1999-11-30 | 2001-06-06 | Stichting Dienst Landbouwkundig Onderzoek | Mono- und Disaccharidederivate die sowohl Fettsäureestern als Sulfatestern enthalten |
AT408150B (de) * | 2000-04-14 | 2001-09-25 | Oesterr Forsch Seibersdorf | Verfahren zur immobilisierung eines analyten an einer festen oberfläche |
FR2808691B1 (fr) | 2000-05-12 | 2005-06-24 | Coletica | Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine |
FR2825714B1 (fr) * | 2001-06-08 | 2005-03-25 | Seppic Sa | Nouvelle utilisation de complexes d'inclusion de cyclodestrine |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
EP1496916A2 (de) * | 2002-04-09 | 2005-01-19 | Greenville Hospital System | Metastasen-modulierende wirkung von hochsulfierten oligosacchariden |
EP2591786B1 (de) * | 2003-10-16 | 2017-04-12 | Cancure Limited | Immunmodulierende Zusammensetzungen und ihre Verwendung |
CA2631014C (en) | 2005-11-28 | 2015-04-28 | Vernon D. Rowe | Compositions useful for reducing nephrotoxicity and methods of use thereof |
US20090017064A1 (en) * | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
AU2008324780A1 (en) | 2007-11-06 | 2009-05-14 | Pah W Llc | Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine |
EP2062594A1 (de) * | 2007-11-21 | 2009-05-27 | Wyeth Farma, S.A. | Impfstoff und immunogene Zusammensetzung gegen den Blauzungenvirus, Verfahren zu deren Verwendung und Verfahren zu deren Herstellung |
US8192721B2 (en) * | 2007-12-13 | 2012-06-05 | Verrow Pharmaceuticals, Inc. | Compositions useful for reducing toxicity associated with gadolinium-based contrast agents |
PE20110023A1 (es) | 2009-06-22 | 2011-01-31 | Wyeth Llc | Composiciones inmunogenicas de antigenos de staphylococcus aureus |
EP3461496B1 (de) | 2009-06-22 | 2023-08-23 | Wyeth LLC | Zusammensetzungen und verfahren zur herstellung von staphylococcus aureus serotyp-5 und 8-kapselpolysaccharid-konjugat-immunogenzusammensetzungen |
US20110110980A1 (en) * | 2009-09-02 | 2011-05-12 | Wyeth Llc | Heterlogous prime-boost immunization regimen |
EP2397484A1 (de) | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Trisaccharidderivate und ihre Verwendung als Adjuvantien |
RU2580620C2 (ru) | 2010-08-23 | 2016-04-10 | ВАЙЕТ ЭлЭлСи | СТАБИЛЬНЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Neisseria meningitidis rLP2086 |
PE20140173A1 (es) | 2010-09-10 | 2014-02-20 | Wyeth Llc | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis |
CN101972477B (zh) * | 2010-10-21 | 2012-09-26 | 中国医学科学院医学生物学研究所 | 磷酸锌疫苗佐剂 |
KR20130114210A (ko) | 2010-12-22 | 2013-10-16 | 와이어쓰 엘엘씨 | 스타필로코커스 아우레우스 항원의 안정한 면역원성 조성물 |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
MY198910A (en) | 2012-03-09 | 2023-10-02 | Pfizer | Neisseria meningitidis compositions and methods thereof |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
PL3363806T3 (pl) | 2012-12-20 | 2022-12-19 | Pfizer Inc. | Sposób glikokoniugacji |
EP2964665B1 (de) | 2013-03-08 | 2018-08-01 | Pfizer Inc | Immunogene fusionspolypeptide |
MX369534B (es) | 2013-09-08 | 2019-11-11 | Pfizer | Composiciones de neisseria meningitidis y sus metodos. |
KR102319843B1 (ko) | 2013-09-25 | 2021-10-29 | 조에티스 서비시즈 엘엘씨 | Pcv2b 분지형 백신 조성물 및 사용 방법 |
CN104013955B (zh) * | 2014-06-18 | 2016-02-24 | 中国科学院过程工程研究所 | 一种不含表面活性剂的水包油乳液及其用途 |
CN104086676B (zh) * | 2014-07-18 | 2017-01-25 | 江苏省农业科学院 | 一种环糊精酯化衍生物、制备方法及其应用 |
ES2759542T3 (es) * | 2014-07-24 | 2020-05-11 | Litevax B V | Adyuvantes |
CN107249626A (zh) | 2015-02-19 | 2017-10-13 | 辉瑞大药厂 | 脑膜炎奈瑟球菌组合物及其方法 |
TWI718144B (zh) | 2015-05-04 | 2021-02-11 | 美商輝瑞股份有限公司 | B型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途 |
US10751402B2 (en) | 2016-11-09 | 2020-08-25 | Pfizer Inc. | Immunogenic compositions and uses thereof |
SG11201906519RA (en) | 2017-01-31 | 2019-08-27 | Pfizer | Neisseria meningitidis compositions and methods thereof |
CN106928378A (zh) * | 2017-03-29 | 2017-07-07 | 中国药科大学 | 一种十二酰基‑β‑环糊精的制备方法和用于色氨酸手性拆分的聚砜膜的制备方法 |
US11433139B2 (en) | 2018-03-16 | 2022-09-06 | Zoetis Services Llc | Peptide vaccines against interleukin-31 |
EP4203995A1 (de) | 2020-08-26 | 2023-07-05 | Pfizer Inc. | Gruppe-b-streptococcus-polysaccharid-protein-konjugate, verfahren zur herstellung von konjugaten, immunogene zusammensetzungen mit konjugaten und verwendungen davon |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3565887A (en) * | 1968-05-15 | 1971-02-23 | Corn Products Co | Unsaturated and long chain esters of cyclodextrin |
US4247535A (en) * | 1979-11-05 | 1981-01-27 | American Cyanamid Company | Modified cyclodextrin sulfate salts as complement inhibitors |
US5760015A (en) * | 1988-01-19 | 1998-06-02 | The Trustees Of The University Of Pennsylvania | Cyclodextrin compounds and methods of making and use thereof |
US5658894A (en) * | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
EP0518930A4 (en) * | 1990-03-02 | 1993-09-15 | Australian Commercial Research & Development Limited | Cyclodextrin compositions and methods for pharmaceutical and industrial applications |
FR2672496B3 (fr) * | 1990-07-18 | 1993-05-28 | Vacsyn France Sa | Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique. |
US5180716A (en) * | 1990-08-01 | 1993-01-19 | The Regents Of The University Of California | Cyclodextrin complexes for neuraxial administration of drugs |
IT1242214B (it) * | 1990-11-13 | 1994-03-03 | Emo Chiellini | Derivati polifunzionali delle ciclodestrine |
JP2556236B2 (ja) * | 1991-08-29 | 1996-11-20 | 田辺製薬株式会社 | β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法 |
CA2085827C (en) * | 1991-12-23 | 2003-10-14 | Lucas A. T. Hilgers | Adjuvant composition containing synthetic hydrophobic lipopolysaccharide |
WO1993017711A1 (en) * | 1992-03-11 | 1993-09-16 | Australian Commercial Research & Development Limited | New cyclodextrins and new formulated drugs |
DE4220734A1 (de) * | 1992-06-25 | 1994-01-05 | Puetter Medice Chem Pharm | Lipophile Cyclodextrinpolymere |
US5464827A (en) * | 1994-06-20 | 1995-11-07 | American Home Products Corporation | Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
BE1008978A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
-
1994
- 1994-12-27 BE BE9401174A patent/BE1008978A5/fr active
-
1995
- 1995-12-21 DE DE69520376T patent/DE69520376T2/de not_active Expired - Lifetime
- 1995-12-21 EP EP95942007A patent/EP0814836B1/de not_active Expired - Lifetime
- 1995-12-21 US US08/860,454 patent/US6165995A/en not_active Expired - Lifetime
- 1995-12-21 US US08/860,453 patent/US6328965B1/en not_active Expired - Lifetime
- 1995-12-21 SI SI9530679T patent/SI0800539T1/xx unknown
- 1995-12-21 DK DK95942007T patent/DK0814836T3/da active
- 1995-12-21 PT PT95942007T patent/PT814836E/pt unknown
- 1995-12-21 PT PT95942008T patent/PT800539E/pt unknown
- 1995-12-21 CA CA2208790A patent/CA2208790C/en not_active Expired - Lifetime
- 1995-12-21 JP JP52008196A patent/JP3927235B2/ja not_active Expired - Lifetime
- 1995-12-21 CA CA002208849A patent/CA2208849C/en not_active Expired - Lifetime
- 1995-12-21 CN CN95197099A patent/CN1132630C/zh not_active Expired - Lifetime
- 1995-12-21 AT AT95942007T patent/ATE199644T1/de active
- 1995-12-21 ES ES95942008T patent/ES2204969T3/es not_active Expired - Lifetime
- 1995-12-21 MX MX9704822A patent/MX9704822A/es unknown
- 1995-12-21 BR BR9510223A patent/BR9510223A/pt not_active IP Right Cessation
- 1995-12-21 AU AU43248/96A patent/AU709104B2/en not_active Ceased
- 1995-12-21 WO PCT/BE1995/000119 patent/WO1996020008A1/fr active IP Right Grant
- 1995-12-21 AU AU43249/96A patent/AU713997B2/en not_active Ceased
- 1995-12-21 ES ES95942007T patent/ES2155540T3/es not_active Expired - Lifetime
- 1995-12-21 AT AT95942008T patent/ATE248863T1/de active
- 1995-12-21 WO PCT/BE1995/000120 patent/WO1996020222A1/en active IP Right Grant
- 1995-12-21 EP EP95942008A patent/EP0800539B1/de not_active Expired - Lifetime
- 1995-12-21 JP JP52008296A patent/JP4087900B2/ja not_active Expired - Lifetime
- 1995-12-21 BR BR9510263A patent/BR9510263A/pt not_active IP Right Cessation
- 1995-12-21 CN CN95197557A patent/CN1109049C/zh not_active Expired - Lifetime
- 1995-12-21 DE DE69531699T patent/DE69531699T2/de not_active Expired - Lifetime
- 1995-12-21 DK DK95942008T patent/DK0800539T3/da active
-
2001
- 2001-05-28 GR GR20010400796T patent/GR3035941T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE199644T1 (de) | Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe | |
ATE410183T1 (de) | Verbesserte adjuvant zusammensetzungen auf basis von saponin und damit zusammenhängende methoden | |
DK0382271T3 (da) | Tocoler som adjuvanser i vacciner | |
DE69529684T2 (de) | Adjuvans für impfstoff | |
ATE196737T1 (de) | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus | |
ES2109929T3 (es) | Procedimiento para preparar un glucano de levadura | |
PT98156A (pt) | Um processo de preparacao de uma composicao de vacina | |
DK55891D0 (da) | Matrix med immunomodulerende virkning | |
IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
NL300185I1 (nl) | Acellulair vaccin. | |
ATE419873T1 (de) | Synthese von lipopolysaccharid-protein konjugatvaccinen über die lipid-a region nach entfernung des glycosidischen phosphatresidüs | |
DK120383A (da) | Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning | |
CA2022420A1 (en) | Escherichia coli vaccine | |
GR3031487T3 (en) | Pasteurella multocida toxoid vaccines. | |
DK0544712T3 (da) | Neuraminidase og galactoseoxidase som vaccineadjuvans | |
CA2086258A1 (en) | Pasteurella multocida toxoid vaccines | |
RO100102B1 (ro) | Vaccin pentru imunoprofilaxia specifica a hipodermozei si procedeu de preparare a acestuia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner |